| Prognostic benefit of surgical management in renal cell carcinoma patients with thrombus extending to the renal vein and inferior vena cava: 17-year experience at a single center S Hatakeyama, T Yoneyama, I Hamano, H Murasawa, T Narita, M Oikawa, ... BMC urology 13, 1-11, 2013 | 69 | 2013 |
| Renal function outcomes and risk factors for risk factors for stage 3B chronic kidney disease after urinary diversion in patients with muscle invasive bladder cancer S Hatakeyama, T Koie, T Narita, S Hosogoe, H Yamamoto, Y Tobisawa, ... PloS one 11 (2), e0149544, 2016 | 49 | 2016 |
| The impact of preoperative severe renal insufficiency on poor postsurgical oncological prognosis in patients with urothelial carcinoma M Momota, S Hatakeyama, N Tokui, T Sato, H Yamamoto, Y Tobisawa, ... European Urology Focus 5 (6), 1066-1073, 2019 | 47 | 2019 |
| Impact of nadir PSA level and time to nadir during initial androgen deprivation therapy on prognosis in patients with metastatic castration-resistant prostate cancer I Hamano, S Hatakeyama, S Narita, M Takahashi, T Sakurai, S Kawamura, ... World journal of urology 37, 2365-2373, 2019 | 38 | 2019 |
| Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer I Hamano, S Hatakeyama, H Iwamurau, N Fujita, K Fukushi, T Narita, ... Oncotarget 8 (37), 61404, 2017 | 34 | 2017 |
| Clinical implications of serum N‐glycan profiling as a diagnostic and prognostic biomarker in germ‐cell tumors T Narita, S Hatakeyama, T Yoneyama, S Narita, S Yamashita, ... Cancer Medicine 6 (4), 739-748, 2017 | 32 | 2017 |
| Switching hemodialysis patients from sevelamer hydrochloride to bixalomer: a single-center, non-randomized analysis of efficacy and effects on gastrointestinal symptoms and … S Hatakeyama, H Murasawa, T Narita, M Oikawa, N Fujita, H Iwamura, ... BMC nephrology 14, 1-7, 2013 | 31 | 2013 |
| The influence of serum uric acid on renal function in patients with calcium or uric acid stone: a population-based analysis Y Tanaka, S Hatakeyama, T Tanaka, H Yamamoto, T Narita, I Hamano, ... PloS one 12 (7), e0182136, 2017 | 28 | 2017 |
| Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study) T Hamaya, S Hatakeyama, M Momota, T Narita, H Iwamura, Y Kojima, ... International Journal of Clinical Oncology 26, 199-206, 2021 | 27 | 2021 |
| Significance of serum N-glycan profiling as a diagnostic biomarker in urothelial carcinoma M Oikawa, S Hatakeyama, T Yoneyma, Y Tobisawa, T Narita, ... European Urology Focus 4 (3), 405-411, 2018 | 27 | 2018 |
| Clinical relevance of aortic calcification in urolithiasis patients T Tanaka, S Hatakeyama, H Yamamoto, T Narita, I Hamano, T Matsumoto, ... BMC urology 17, 1-9, 2017 | 27 | 2017 |
| Prognosis of elderly Japanese patients aged≥ 80 years undergoing hemodialysis S Hatakeyama, H Murasawa, I Hamano, A Kusaka, T Narita, M Oikawa, ... The Scientific World Journal 2013 (1), 693514, 2013 | 22 | 2013 |
| Association of tumor burden with the eligibility of upfront intensification therapy in metastatic castration‐sensitive prostate cancer: A multicenter retrospective study S Hatakeyama, S Narita, M Takahashi, T Sakurai, S Kawamura, S Hoshi, ... International Journal of Urology 27 (7), 610-617, 2020 | 20 | 2020 |
| The impact of extended lymph node dissection versus neoadjuvant therapy with limited lymph node dissection on biochemical recurrence in high-risk prostate cancer patients … T Narita, T Koie, T Ookubo, K Mitsuzuka, S Narita, H Yamamoto, T Inoue, ... Medical Oncology 34, 1-6, 2017 | 20 | 2017 |
| Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer A Kusaka, S Hatakeyama, S Hosogoe, I Hamano, H Iwamura, N Fujita, ... Medical Oncology 34, 1-10, 2017 | 18 | 2017 |
| Quality-of-life evaluation during platinum-based neoadjuvant chemotherapies for urothelial carcinoma K Fukushi, T Narita, S Hatakeyama, H Yamamoto, O Soma, T Matsumoto, ... International journal of clinical oncology 22 (2), 366-372, 2017 | 17 | 2017 |
| Comparison of pembrolizumab with conventional chemotherapy after first‐line platinum‐based chemotherapy for advanced urothelial carcinoma in real‐world practice: a multicenter … T Narita, S Hatakeyama, K Numakura, M Kobayashi, Y Muto, M Saito, ... International Journal of Urology 28 (9), 899-905, 2021 | 16 | 2021 |
| Cost-effectiveness comparison between neoadjuvant chemohormonal therapy and extended pelvic lymph node dissection in high-risk prostate cancer patients treated with radical … T Matsumoto, S Hatakeyama, T Ookubo, K Mitsuzuka, S Narita, T Inoue, ... Medical Oncology 34, 1-9, 2017 | 16 | 2017 |
| Prognostic impact of proton pump inhibitors for immunotherapy in advanced urothelial carcinoma Y Okuyama, S Hatakeyama, K Numakura, T Narita, T Tanaka, Y Miura, ... BJUI compass 3 (2), 154-161, 2022 | 15 | 2022 |
| Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer N Fujita, S Hatakeyama, M Momota, K Kido, T Narita, Y Tobisawa, ... Urologic Oncology: Seminars and Original Investigations 38 (8), 684. e17-684 …, 2020 | 15 | 2020 |
